Medicare Enrolled
Dr. Hisham El-Kadi, MD
Rheumatology · Freehold, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. El-Kadi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El-Kadi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. El-Kadi
Dr. Hisham El-Kadi is a rheumatology specialist in Freehold, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. El-Kadi performed 250,826 Medicare services across 4,526 unique beneficiaries.
Between the years covered by Open Payments, Dr. El-Kadi received a total of $5,098 from 30 pharmaceutical and/or device companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. El-Kadi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NJ
$5,098 industry payments
Medicare Practice Summary
Medicare Utilization ↗250,826
Medicare services
Top 1% in NJ for rheumatology
4,526
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~12,541 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 89,281 | $4 | $6 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
52,800 | $4 | $8 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
24,200 | $34 | $65 |
| Denosumab injection (Prolia/Xgeva) | 23,702 | $18 | $24 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
20,602 | $11 | $30 |
| Acetaminophen injection, 10 mg An injection containing 10 mg of acetaminophen administered to the patient. |
15,205 | $0 | $1 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
10,480 | $26 | $100 |
| Joint lubricant injection (Durolane) An injection of hyaluronan or its derivative, specifically Durolane, administered directly into a joint space. |
3,367 | $5 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,632 | $102 | $150 |
| Injection, methylprednisolone acetate, 40 mg | 1,344 | $6 | $10 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
951 | $62 | $100 |
| Methotrexate sodium, 50 mg | 898 | $2 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
863 | $112 | $250 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
763 | $67 | $181 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
542 | $9 | $15 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
308 | $56 | $250 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
294 | $25 | $100 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
224 | $27 | $100 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
218 | $33 | $132 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
214 | $3 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
199 | $75 | $110 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
187 | $14 | $100 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
169 | $43 | $200 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
163 | $4 | $50 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
159 | $36 | $150 |
| Tendon injection at attachment site A procedure involving the injection of medication into a tendon where it attaches to bone or muscle. |
140 | $28 | $110 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
126 | $40 | $164 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
105 | $7 | $260 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
89 | $1 | $5 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $134 | $200 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
87 | $1 | $25 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
82 | $4 | $5 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
79 | $33 | $125 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
67 | $33 | $50 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
65 | $72 | $74 |
| Hyaluronan intra-articular injection An injection of hyaluronan or a derivative into a joint to provide lubrication and cushioning. |
55 | $561 | $1,527 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $142 | $215 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
37 | $138 | $172 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.5% high complexity
75.8% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,098
Total received (2018-2024)
Avg $728/year across 7 years
Top 33% in NJ for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
322
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,078 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$856
2023
$1,192
2022
$976
2021
$768
2020
$450
2019
$478
2018
$379
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$426
Novartis Pharmaceuticals Corporation
$103
Zimmer Biomet Holdings, Inc.
$71
E.R. Squibb & Sons, L.L.C.
$63
Amgen Inc.
$62
UCB, Inc.
$34
Bioventus LLC
$25
BIOTRONIK NRO, Inc.
$21
GENZYME CORPORATION
$21
Janssen Biotech, Inc.
$15
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 70.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,000
ABBVIE INC.
$714
Novartis Pharmaceuticals Corporation
$556
E.R. Squibb & Sons, L.L.C.
$453
Janssen Biotech, Inc.
$367
UCB, Inc.
$301
PFIZER INC.
$268
Horizon Therapeutics plc
$223
AbbVie, Inc.
$183
GlaxoSmithKline, LLC.
$141
Bioventus LLC
$105
AbbVie Inc.
$99
DePuy Synthes Sales Inc.
$82
Lilly USA, LLC
$82
Zimmer Biomet Holdings, Inc.
$71
Aurinia Pharma U.S., Inc.
$62
Genentech USA, Inc.
$62
GENZYME CORPORATION
$59
AstraZeneca Pharmaceuticals LP
$50
Merck Sharp & Dohme Corporation
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Avanos Medical
$26
Radius Health, Inc.
$25
BIOTRONIK NRO, Inc.
$21
Fresenius Kabi USA, LLC
$17
Pacira Pharmaceuticals Incorporated
$16
Organon LLC
$15
Sebela Pharmaceuticals Inc.
$14
Hikma Pharmaceuticals USA
$14
SANOFI-AVENTIS U.S. LLC
$13
Top 3 companies account for 44.5% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · AVSOLA · Actemra · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · DUROLANE · Durolane · EVENITY · Enbrel · Exparel · GELSYN 3 · Gel-One Cross-linked Hyaluronate · HUMIRA · Humira · IDACIO · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OFEV · ON-Q* PUMP AND ACCESSORIES · ORENCIA · Prospera · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
61
Per 100K population
9.5
County median income
$122,727
Nearest hospital
CENTRASTATE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. El-Kadi is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. El-Kadi experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. El-Kadi performed 89,281 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El-Kadi receive payments from pharmaceutical companies?
Yes. Dr. El-Kadi received a total of $5,098 from 30 companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El-Kadi's costs compare to other rheumatologists in Freehold?
Dr. El-Kadi's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El-Kadi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Freehold
Browse rheumatologists in Freehold ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NJ
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NJ
Which NJ rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology